Veradigm Inc. (MDRX) - Total Liabilities

Latest as of September 2022: $513.64 Million USD

Based on the latest financial reports, Veradigm Inc. (MDRX) has total liabilities worth $513.64 Million USD as of September 2022. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Veradigm Inc. to see how much of total assets are deployed in long-term investments.

Veradigm Inc. - Total Liabilities Trend (1998–2024)

This chart illustrates how Veradigm Inc.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Veradigm Inc. (MDRX) total assets.

Veradigm Inc. Competitors by Total Liabilities

The table below lists competitors of Veradigm Inc. ranked by their total liabilities.

Company Country Total Liabilities
Chongqing Yukaifa Co Ltd
SHE:000514
China CN¥2.78 Billion
London Stock Exchange Group PLC
LSE:LSEG
UK GBX788.25 Billion
Italtile Ltd
JSE:ITE
South Africa ZAC1.97 Billion
UPC Technology Corp
TW:1313
Taiwan NT$25.50 Billion
4D Molecular Therapeutics Inc
NASDAQ:FDMT
USA $61.05 Million
Guangdong Brandmax Marketing Co Ltd
SHE:300805
China CN¥650.48 Million
Meorient
SHE:300795
China CN¥208.64 Million
Pansoft Company Limited
SHE:300996
China CN¥169.81 Million

Liability Composition Analysis (1998–2024)

This chart breaks down Veradigm Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See MDRX net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.44 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Veradigm Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Veradigm Inc. (1998–2024)

The table below shows the annual total liabilities of Veradigm Inc. from 1998 to 2024.

Year Total Liabilities Change
2024-12-31 $487.22 Million 0.00%
2022-12-31 $487.22 Million -52.10%
2021-12-31 $1.02 Billion -18.72%
2020-12-31 $1.25 Billion -34.84%
2019-12-31 $1.92 Billion +19.95%
2018-12-31 $1.60 Billion -39.32%
2017-12-31 $2.64 Billion +21.52%
2016-12-31 $2.17 Billion +71.93%
2015-12-31 $1.26 Billion +7.02%
2014-12-31 $1.18 Billion -9.33%
2013-12-31 $1.30 Billion +22.19%
2012-12-31 $1.07 Billion +2.36%
2011-12-31 $1.04 Billion +0.56%
2010-12-31 $1.03 Billion +310.15%
2009-12-31 $252.30 Million +0.01%
2008-12-31 $252.29 Million 0.00%
2007-12-31 $252.29 Million +56.35%
2006-12-31 $161.36 Million +31.67%
2005-12-31 $122.55 Million +6.11%
2004-12-31 $115.48 Million +327.69%
2003-12-31 $27.00 Million +45.70%
2002-12-31 $18.53 Million -1.48%
2001-12-31 $18.81 Million +30.22%
2000-12-31 $14.45 Million +118.40%
1999-12-31 $6.61 Million -49.89%
1998-12-31 $13.20 Million --

About Veradigm Inc.

NASDAQ:MDRX USA Health Information Services
Market Cap
$527.79 Million
Market Cap Rank
#12184 Global
#3053 in USA
Share Price
$4.85
Change (1 day)
+5.46%
52-Week Range
$4.20 - $5.99
All Time High
$23.09
About

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle se… Read more